RXi Pharmaceuticals Corporation ( RXII ) was a big mover last session, as its shares rose almost 29% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend of the company, as it is now trading above the volatile price range of $4.25 to $5.10 in the past one-month timeframe.
In the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, suggesting trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher lasts.
RXi Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. ( WX ), BioCryst Pharmaceuticals, Inc. ( BCRX ) and Aratana Therapeutics, Inc. ( PETX ). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
BIOCRYST PHARMA (BCRX): Free Stock Analysis Report
ARATANA THERAP (PETX): Free Stock Analysis Report
RXI PHARMACEUT (RXII): Get Free Report
WUXI PHARMATECH (WX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research